OBJECTIVE

To explore the effect of tumor plastic surgery on the repair of large-area skin defects after maxillofacial tumor resection.

METHODS

90 patients undergoing maxillofacial tumor resection in our hospital from March 2019 to March 2020 were selected and randomized 1 : 1 to receive either tumor plastic surgery (experimental group) or traditional repair (control group). The clinical efficacy and facial cosmetic improvement of the two groups were compared. The Patient and Observer Scar Assessment Scale (POSAS) was used to evaluate the surgical outcomes of the two groups, the Profile of Mood States (POMS) was used to evaluate the patients' psychological status, and the Generic Quality of Life Inventory-74 (GQOLI-74) was used to assess the quality of life of patients.

RESULTS

Total clinical effective rate of the experimental group was significantly higher than that of the control group ( < 0.001). A higher excellent rate of facial cosmetic improvement was observed in the experimental group versus the control group ( < 0.001). Significantly lower POSAS scores of the experimental group than the control group were observed ( < 0.001). The POMS scores of the experimental group after treatment were lower than those of the control group ( < 0.001). Tumor plastic surgery resulted in a remarkably higher GQOLI-74 score in the patients versus traditional repair ( < 0.001).

CONCLUSION

Tumor plastic surgery is a promising alternative for patients undergoing maxillofacial tumor resection. It can effectively promote the recovery of facial morphology and physiological function of patients, with high clinical efficacy, so it merits promotion and application.